CH376911A - Process for the preparation of esters of new halogenpregnane compounds - Google Patents
Process for the preparation of esters of new halogenpregnane compoundsInfo
- Publication number
- CH376911A CH376911A CH6947959A CH6947959A CH376911A CH 376911 A CH376911 A CH 376911A CH 6947959 A CH6947959 A CH 6947959A CH 6947959 A CH6947959 A CH 6947959A CH 376911 A CH376911 A CH 376911A
- Authority
- CH
- Switzerland
- Prior art keywords
- methyl
- halogen compounds
- acid
- group
- hydroxy
- Prior art date
Links
- 238000000034 method Methods 0.000 title claims description 17
- 150000002148 esters Chemical class 0.000 title claims description 6
- 238000002360 preparation method Methods 0.000 title claims description 4
- 150000001875 compounds Chemical class 0.000 title description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims description 9
- 239000000203 mixture Substances 0.000 claims description 8
- 230000003647 oxidation Effects 0.000 claims description 8
- 238000007254 oxidation reaction Methods 0.000 claims description 8
- 238000006243 chemical reaction Methods 0.000 claims description 7
- 229910052731 fluorine Inorganic materials 0.000 claims description 5
- 239000011737 fluorine Substances 0.000 claims description 5
- KRHYYFGTRYWZRS-UHFFFAOYSA-N Fluorane Chemical compound F KRHYYFGTRYWZRS-UHFFFAOYSA-N 0.000 claims description 4
- 125000004423 acyloxy group Chemical group 0.000 claims description 4
- 229910052801 chlorine Chemical group 0.000 claims description 4
- 239000007858 starting material Substances 0.000 claims description 4
- 125000000468 ketone group Chemical group 0.000 claims description 3
- 150000004965 peroxy acids Chemical class 0.000 claims description 3
- MWMZFISSIWWNPY-FXCQAQFTSA-N 1-[(6S,8R,9S,10R,13S,14S,16R,17S)-6-hydroxy-10,13,16-trimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]ethanone Chemical class C[C@@H]1C[C@H]2[C@@H]3C[C@@H](C4CCCC[C@@]4([C@H]3CC[C@@]2([C@H]1C(=O)C)C)C)O MWMZFISSIWWNPY-FXCQAQFTSA-N 0.000 claims description 2
- GLVYLTSKTCWWJR-UHFFFAOYSA-N 2-carbonoperoxoylbenzoic acid Chemical compound OOC(=O)C1=CC=CC=C1C(O)=O GLVYLTSKTCWWJR-UHFFFAOYSA-N 0.000 claims description 2
- YNJSNEKCXVFDKW-UHFFFAOYSA-N 3-(5-amino-1h-indol-3-yl)-2-azaniumylpropanoate Chemical compound C1=C(N)C=C2C(CC(N)C(O)=O)=CNC2=C1 YNJSNEKCXVFDKW-UHFFFAOYSA-N 0.000 claims description 2
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical group [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 claims description 2
- 239000004593 Epoxy Substances 0.000 claims description 2
- 125000002252 acyl group Chemical group 0.000 claims description 2
- 230000015572 biosynthetic process Effects 0.000 claims description 2
- 239000003795 chemical substances by application Substances 0.000 claims description 2
- 239000000460 chlorine Chemical group 0.000 claims description 2
- XENVCRGQTABGKY-ZHACJKMWSA-N chlorohydrin Chemical compound CC#CC#CC#CC#C\C=C\C(Cl)CO XENVCRGQTABGKY-ZHACJKMWSA-N 0.000 claims description 2
- NKRNGKIEDAVMHL-UHFFFAOYSA-L dihydroxy(dioxo)chromium;pyridine Chemical compound O[Cr](O)(=O)=O.C1=CC=NC=C1 NKRNGKIEDAVMHL-UHFFFAOYSA-L 0.000 claims description 2
- 125000001153 fluoro group Chemical group F* 0.000 claims description 2
- WJGAPUXHSQQWQF-UHFFFAOYSA-N acetic acid;hydrochloride Chemical compound Cl.CC(O)=O WJGAPUXHSQQWQF-UHFFFAOYSA-N 0.000 claims 2
- 150000001735 carboxylic acids Chemical class 0.000 claims 1
- 238000006356 dehydrogenation reaction Methods 0.000 claims 1
- 230000001419 dependent effect Effects 0.000 claims 1
- 229910052736 halogen Inorganic materials 0.000 claims 1
- 150000002367 halogens Chemical class 0.000 claims 1
- 229960002050 hydrofluoric acid Drugs 0.000 claims 1
- 229920000647 polyepoxide Polymers 0.000 claims 1
- 239000002243 precursor Substances 0.000 claims 1
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 20
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 14
- 239000000243 solution Substances 0.000 description 13
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 12
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 10
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 9
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 8
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 6
- 229960000583 acetic acid Drugs 0.000 description 6
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 6
- 239000011541 reaction mixture Substances 0.000 description 5
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 4
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 4
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 4
- WTEOIRVLGSZEPR-UHFFFAOYSA-N boron trifluoride Chemical compound FB(F)F WTEOIRVLGSZEPR-UHFFFAOYSA-N 0.000 description 4
- 239000012362 glacial acetic acid Substances 0.000 description 4
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 4
- 235000019341 magnesium sulphate Nutrition 0.000 description 4
- 239000002904 solvent Substances 0.000 description 4
- JOXIMZWYDAKGHI-UHFFFAOYSA-N toluene-4-sulfonic acid Chemical compound CC1=CC=C(S(O)(=O)=O)C=C1 JOXIMZWYDAKGHI-UHFFFAOYSA-N 0.000 description 4
- WFDIJRYMOXRFFG-UHFFFAOYSA-N Acetic anhydride Chemical compound CC(=O)OC(C)=O WFDIJRYMOXRFFG-UHFFFAOYSA-N 0.000 description 3
- -1 B. hydrochloric acid Chemical class 0.000 description 3
- KZMGYPLQYOPHEL-UHFFFAOYSA-N Boron trifluoride etherate Chemical compound FB(F)F.CCOCC KZMGYPLQYOPHEL-UHFFFAOYSA-N 0.000 description 3
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 3
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 3
- KDCIHNCMPUBDKT-UHFFFAOYSA-N hexane;propan-2-one Chemical compound CC(C)=O.CCCCCC KDCIHNCMPUBDKT-UHFFFAOYSA-N 0.000 description 3
- 229910015900 BF3 Inorganic materials 0.000 description 2
- BVKZGUZCCUSVTD-UHFFFAOYSA-M Bicarbonate Chemical class OC([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-M 0.000 description 2
- FERIUCNNQQJTOY-UHFFFAOYSA-N Butyric acid Chemical compound CCCC(O)=O FERIUCNNQQJTOY-UHFFFAOYSA-N 0.000 description 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 description 2
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 2
- KFSLWBXXFJQRDL-UHFFFAOYSA-N Peracetic acid Chemical compound CC(=O)OO KFSLWBXXFJQRDL-UHFFFAOYSA-N 0.000 description 2
- RJKFOVLPORLFTN-LEKSSAKUSA-N Progesterone Chemical compound C1CC2=CC(=O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H](C(=O)C)[C@@]1(C)CC2 RJKFOVLPORLFTN-LEKSSAKUSA-N 0.000 description 2
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 2
- 150000007933 aliphatic carboxylic acids Chemical class 0.000 description 2
- 125000001309 chloro group Chemical group Cl* 0.000 description 2
- 238000004587 chromatography analysis Methods 0.000 description 2
- 238000002425 crystallisation Methods 0.000 description 2
- 230000008025 crystallization Effects 0.000 description 2
- XBDQKXXYIPTUBI-UHFFFAOYSA-N dimethylselenoniopropionate Natural products CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 description 2
- 150000008282 halocarbons Chemical class 0.000 description 2
- FUZZWVXGSFPDMH-UHFFFAOYSA-N hexanoic acid Chemical compound CCCCCC(O)=O FUZZWVXGSFPDMH-UHFFFAOYSA-N 0.000 description 2
- IXCSERBJSXMMFS-UHFFFAOYSA-N hydrogen chloride Substances Cl.Cl IXCSERBJSXMMFS-UHFFFAOYSA-N 0.000 description 2
- 229910000041 hydrogen chloride Inorganic materials 0.000 description 2
- 230000002906 microbiologic effect Effects 0.000 description 2
- VLTRZXGMWDSKGL-UHFFFAOYSA-N perchloric acid Chemical compound OCl(=O)(=O)=O VLTRZXGMWDSKGL-UHFFFAOYSA-N 0.000 description 2
- XNGIFLGASWRNHJ-UHFFFAOYSA-N phthalic acid Chemical compound OC(=O)C1=CC=CC=C1C(O)=O XNGIFLGASWRNHJ-UHFFFAOYSA-N 0.000 description 2
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- JPJALAQPGMAKDF-UHFFFAOYSA-N selenium dioxide Chemical compound O=[Se]=O JPJALAQPGMAKDF-UHFFFAOYSA-N 0.000 description 2
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 2
- 235000017557 sodium bicarbonate Nutrition 0.000 description 2
- 229910000029 sodium carbonate Inorganic materials 0.000 description 2
- GEYOCULIXLDCMW-UHFFFAOYSA-N 1,2-phenylenediamine Chemical compound NC1=CC=CC=C1N GEYOCULIXLDCMW-UHFFFAOYSA-N 0.000 description 1
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 1
- LKPFWCPZERQLFI-UHFFFAOYSA-N 2,4,6-trimethylpyridine;hydrochloride Chemical compound Cl.CC1=CC(C)=NC(C)=C1 LKPFWCPZERQLFI-UHFFFAOYSA-N 0.000 description 1
- JUIKUQOUMZUFQT-UHFFFAOYSA-N 2-bromoacetamide Chemical compound NC(=O)CBr JUIKUQOUMZUFQT-UHFFFAOYSA-N 0.000 description 1
- MSXVEPNJUHWQHW-UHFFFAOYSA-N 2-methylbutan-2-ol Chemical compound CCC(C)(C)O MSXVEPNJUHWQHW-UHFFFAOYSA-N 0.000 description 1
- OMIHGPLIXGGMJB-UHFFFAOYSA-N 7-oxabicyclo[4.1.0]hepta-1,3,5-triene Chemical compound C1=CC=C2OC2=C1 OMIHGPLIXGGMJB-UHFFFAOYSA-N 0.000 description 1
- 241000577959 Calonectria Species 0.000 description 1
- PIICEJLVQHRZGT-UHFFFAOYSA-N Ethylenediamine Chemical compound NCCN PIICEJLVQHRZGT-UHFFFAOYSA-N 0.000 description 1
- 241000427940 Fusarium solani Species 0.000 description 1
- 241000193386 Lysinibacillus sphaericus Species 0.000 description 1
- 241001139337 Mycobacterium lacticola Species 0.000 description 1
- PCLIMKBDDGJMGD-UHFFFAOYSA-N N-bromosuccinimide Chemical compound BrN1C(=O)CCC1=O PCLIMKBDDGJMGD-UHFFFAOYSA-N 0.000 description 1
- 241000203720 Pimelobacter simplex Species 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 229910000288 alkali metal carbonate Inorganic materials 0.000 description 1
- 150000008041 alkali metal carbonates Chemical class 0.000 description 1
- 150000001412 amines Chemical class 0.000 description 1
- 150000008064 anhydrides Chemical class 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 239000002585 base Substances 0.000 description 1
- 150000001732 carboxylic acid derivatives Chemical class 0.000 description 1
- 239000003054 catalyst Substances 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- XTEGARKTQYYJKE-UHFFFAOYSA-N chloric acid Chemical compound OCl(=O)=O XTEGARKTQYYJKE-UHFFFAOYSA-N 0.000 description 1
- 229940005991 chloric acid Drugs 0.000 description 1
- KRVSOGSZCMJSLX-UHFFFAOYSA-L chromic acid Substances O[Cr](O)(=O)=O KRVSOGSZCMJSLX-UHFFFAOYSA-L 0.000 description 1
- 229940117975 chromium trioxide Drugs 0.000 description 1
- WGLPBDUCMAPZCE-UHFFFAOYSA-N chromium trioxide Inorganic materials O=[Cr](=O)=O WGLPBDUCMAPZCE-UHFFFAOYSA-N 0.000 description 1
- GAMDZJFZMJECOS-UHFFFAOYSA-N chromium(6+);oxygen(2-) Chemical compound [O-2].[O-2].[O-2].[Cr+6] GAMDZJFZMJECOS-UHFFFAOYSA-N 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 230000018044 dehydration Effects 0.000 description 1
- 238000006297 dehydration reaction Methods 0.000 description 1
- HPNMFZURTQLUMO-UHFFFAOYSA-N diethylamine Chemical compound CCNCC HPNMFZURTQLUMO-UHFFFAOYSA-N 0.000 description 1
- PSYHTTIHEIYHBE-UHFFFAOYSA-L dihydroxy(dioxo)chromium;propan-2-one;sulfuric acid Chemical compound CC(C)=O.OS(O)(=O)=O.O[Cr](O)(=O)=O PSYHTTIHEIYHBE-UHFFFAOYSA-L 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 150000002170 ethers Chemical class 0.000 description 1
- 238000001640 fractional crystallisation Methods 0.000 description 1
- AWJWCTOOIBYHON-UHFFFAOYSA-N furo[3,4-b]pyrazine-5,7-dione Chemical compound C1=CN=C2C(=O)OC(=O)C2=N1 AWJWCTOOIBYHON-UHFFFAOYSA-N 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 150000004820 halides Chemical class 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 229910000040 hydrogen fluoride Inorganic materials 0.000 description 1
- 238000005984 hydrogenation reaction Methods 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 150000004679 hydroxides Chemical class 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 150000003949 imides Chemical class 0.000 description 1
- 238000006317 isomerization reaction Methods 0.000 description 1
- 150000002576 ketones Chemical class 0.000 description 1
- 239000000155 melt Substances 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- 230000008018 melting Effects 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- WSSOFBRSFAPKKC-UHFFFAOYSA-N n-bromoformamide Chemical class BrNC=O WSSOFBRSFAPKKC-UHFFFAOYSA-N 0.000 description 1
- 150000004967 organic peroxy acids Chemical class 0.000 description 1
- 239000007800 oxidant agent Substances 0.000 description 1
- TWNQGVIAIRXVLR-UHFFFAOYSA-N oxo(oxoalumanyloxy)alumane Chemical compound O=[Al]O[Al]=O TWNQGVIAIRXVLR-UHFFFAOYSA-N 0.000 description 1
- 229910000027 potassium carbonate Inorganic materials 0.000 description 1
- 239000000186 progesterone Substances 0.000 description 1
- 229960003387 progesterone Drugs 0.000 description 1
- 235000019260 propionic acid Nutrition 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- IUVKMZGDUIUOCP-BTNSXGMBSA-N quinbolone Chemical compound O([C@H]1CC[C@H]2[C@H]3[C@@H]([C@]4(C=CC(=O)C=C4CC3)C)CC[C@@]21C)C1=CCCC1 IUVKMZGDUIUOCP-BTNSXGMBSA-N 0.000 description 1
- 230000035484 reaction time Effects 0.000 description 1
- 229940000207 selenious acid Drugs 0.000 description 1
- 229940065287 selenium compound Drugs 0.000 description 1
- 150000003343 selenium compounds Chemical class 0.000 description 1
- MCAHWIHFGHIESP-UHFFFAOYSA-N selenous acid Chemical compound O[Se](O)=O MCAHWIHFGHIESP-UHFFFAOYSA-N 0.000 description 1
- 239000000741 silica gel Substances 0.000 description 1
- 229910002027 silica gel Inorganic materials 0.000 description 1
- 238000005507 spraying Methods 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 150000003509 tertiary alcohols Chemical class 0.000 description 1
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 1
- 238000001665 trituration Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J13/00—Normal steroids containing carbon, hydrogen, halogen or oxygen having a carbon-to-carbon double bond from or to position 17
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J7/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J75/00—Processes for the preparation of steroids in general
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Steroid Compounds (AREA)
Description
Verfahren zur Herstellung von Estern neuer Halogenpregnanverbindungen Gegenstand des vorliegenden Patentes ist ein Verfahren zur Herstellung von Estern neuer 17a- Hydroxypregnene der Formel
EMI0001.0004
worin X Fluor oder Chlor und R einen Acylrest einer Carbonsäure bedeuten.
Es besteht darin, dass man ein 45;17(20)-3fl,20-Diacyloxy-16a-methyl-pre- gnadien der Formel
EMI0001.0009
worin Ac eine Acylgruppe bedeutet, mit einer Per säure oxydiert, anschliessend die Acyloxygruppen hydrolysiert, in den erhaltenen 3,17a-Dihydroxy- 5a,6a-oxido-16a-methyl-pregnan-20-onen die 3- Hydroxygruppe zur Ketogruppe oxydiert und vor oder nach dieser Oxydation die 5a,6a-Oxidogruppe zum 6p,
5a-Fluor- oder -Chlor-hydrin öffnet, die 5a-Hydroxygruppe unter Eildung der 4,5-Dop- pelbindung abspaltet, die erhaltenen 6p-Halogen- zu 6a-Halogenverbindungen isomerisiert und auf belie biger Reaktionsstufe nach der Oxydation in 3-Stel- lung die 17a-Hydroxygruppe verestcrt. In den ge wonnenen 44-3,
20-Dioxo-17a-acyloxy-16a-methyl-6a- fluor- oder -6a-chlor-pregnenen kann ausserdem in 1,2-Stellung eine Doppelbindung eingeführt werden.
Das Verfahren ist im nachstehenden Formel schema veranschaulicht:
EMI0002.0001
Für die verfahrensgemässe Oxydation der Aus gangsstoffe verwendet man z. B. organische Per- säuren,insbesondere Perbenzoesäure, Monoperphthal- säure oder Peressigsäure, in Gegenwart eines ge- eigneten Lösungsmittels, wie Äther und; oder haloge- nierter Kohlenwasserstoffe.
Die Acyloxygruppen in den gebildeten 5,6;17,20- Diepoxyden werden vorteilhaft mit alkalischen Mitteln hydrolysiert. Man verwendet dazu z. B. Lösungen von Alkalimetallcarbonaten, bicarbonaten oder -hydrox- yden in wässerigem Methanol oder Äthanol, Dioxan- oder Tetrahydrofuran. Ausserdem sind Amine, wie z.
B. Diäthylamin, Äthylendiamin oder o-Phenylen- diamin, verwendbar. Es ist zweckmässig, das im Hydrolyseprodukt in überwiegender Menge enthal tene 5a,6a-Oxido-3ss,17a-dihydroxy-16a-methyl-20- oxo-pregnan vor der nächsten Reaktionsstufe durch Kristallisation und.'oder Chromatographie an Alu miniumoxyd vom 5P,6ss-Isomeren abzutrennen.
Für die Oxydation der Hydroxygruppe in 3- Stellung zur Ketogruppe eignen sich solche Oxy dationsmittel, welche die Seitenkette unverändert las sen, z. B. Chromsäure-Pyridin-Komplex, oder bei kur zer Reaktionszeit auch Chromsäure-Schwefelsäure- Aceton-Gemisch, ferner N-Chlor- oder N-Brom- carbonsäureamide oder -imide, z. B. Bromsuccinimid oder Bromacetamid in wässrigen Lösungen, z. B.
wässrigem Aceton oder Pyridin.
Die Aufspaltung des 5a,6a-Epoxyds zur Bildung der 6ss-Fluor- oder 6ss-Chlor-5a-hydroxyverbindun- gen erfolgt, wie gesagt, vor oder nach Oxydation der 3-Hydroxy- zur 3-Ketogruppe. Dazu kann man Chlor- oder Fluorwasserstoffsäure in einem Lösungs mittel verwenden, z.
B. in Alkoholen, Ketonen, Äthern, halogenierten Kohlenwasserstoffen, wie Me- thylenchlorid oder Chloroform, vorzugsweise in niederen aliphatischen Carbonsäuren, wie Eisessig oder Propionsäure usw., oder in Gemischen der genannten Lösungsmittel, vorteilhaft bei Tempe raturen zwischen 0-30 .
Anstelle von Chlor- oder Fluorwasserstoff kann man auch Pyridin- oder Colli- dinhydrochlorid oder Bortrifluorid-Ätherat in Benzol zur Aufspaltung des 5a,6a-Epoxyds verwenden. Bei diesen Umsetzungen erhält man die 5a-Hydroxyver- bindungen mit einem 6ss-ständigen Fluor- oder Chlor atom. 3-Hydroxyverbindungen werden nun zu den entsprechenden 3-Ketonen oxydiert, wobei die oben aufgeführten Oxydationsmittel Verwendung finden können.
Zur Abspaltung von Wasser können die 3- Oxo-5a-hydroxy-6ss-halogenverbindungen mit Basen, z. B. Kaliumhydroxyd, oder Säuren, z. B. Salzsäure, behandelt werden. Dabei werden die 44-3-Keto-6ss- halogenverbindungen erhalten. Je nach den verwen deten Reaktionsbedingungen, z. B. Öffnung des Epoxyds mittels Salzsäuregas in Eisessig, können in einer Reaktionsstufe die 44-3-Keto-6a-halogen- verbindungen gebildet werden.
Die Isomerisierung der J4-3-Keto-6ss-halogen- zu den 44-3-Keto-6a- halogenverbindungen erfolgt zweckmässig mittels Chlorwasserstoffgas in Eisessig.
Die Ester der erhaltenen 17a-Hydroxyverbindun- gen werden erhalten, indem man sie z. B. in bekann ter Weise mit Halogeniden oder Anhydriden von z. B. aliphatischen Carbonsäuren, z. B. der Essig-, Propion-, Butter-, insbesondere Capronsäure, um setzt, vorteilhaft in Gegenwart eines Katalysators, wie Pyridin, p-Toluolsulfonsäure oder Perchlorsäure.
Die Einführung der 1,2-Doppelbindung in den erhaltenen 44-3,20-Dioxo-17a-acyloxy-16a-methyl- pregnenen, die in 6a-Stellung ein Fluor- oder Chlor atom aufweisen, kann mittels dehydrierend wirkender Selenverbindungen, z. B. Selendioxyd oder seleniger Säure, in einem tertiären Alkohol, wie Amylenhydrat oder tert. Butanol, oder durch mikrobiologische De hydrierung erreicht werden.
Für die mikrobiologische Dehydrierung eignen sich verschiedene für diese Reaktion bekannte Mikroorganismen, wie z. B. Di- dymella lycopersici, Corynebacterium simplex, Ba- cillus sphaericus, Mycobacterium lacticola, Fusarium solani, Calonectria decora.
Die als Ausgangsstoffe verwendeten d5;17("0)- 3,20-Diacyloxy-16a-methyl-pregnadiene sind neu; sie lassen sich nach dem Verfahren der schweizerischen Patentschrift Nr. 368490 gewinnen.
Die als Endstoffe erhaltenen 17a-Ester sowie ihre d1-Derivate, wie 17a-Acetate, 17a-Capronate von 44-6a-Fluor-16a-methyl-17a-hydroxypregnen- 3,20-dion, 44-6a-Chlor-16a-methyl-17a-hydroxy- pregnen-3,20-dion, d1-4-6a-Fluor-16a-methyl-17a-hy- droxy-pregnadien-3,20-dion und 41,4-6a-Chlor-16a-me- thyl-17a-hydroxy-pregnad'ien-3,20-dion zeichnen sich durch eine hohe progestative Wirkung aus,
die der jenigen des natürlichen Hormons Progesteron über legen ist.
Die Temperaturen sind in den nachfolgenden Beispielen, welche nur Ausführungsformen von ein zelnen Stufen des erfindungsgemässen Verfahrens beschreiben, in Celsiusgraden angegeben. <I>Beispiel 1</I> 4,1 g 45:17(2o)-3ss,20-Diacetoxy-16a.-methyl-pre- gnadien, gelöst in 30 ml Äther, werden mit 52 ml einer 0,575 molaren, ätherischen Phthalmonopersäure- lösung versetzt und 48 Stunden im Dunkeln bei Zimmertemperatur stehengelassen,
wonach die ent standene Phthalsäure und überschüssige Phthalmono- persäure durch Ausschütteln mit wässriger Natrium- carbonatlösung entfernt werden. Nach dem Trocknen der ätherischen Lösung mit Magnesiumsulfat und Abdampfen des Lösungsmittels wird der Rückstand durch Anreiben mit Methanol zur Kristallisation ge bracht. Das so gewonnene Diepoxyd ist ein Gemisch der vier möglichen Isomeren, die sich durch die Kon figuration in den Stellungen 5, 6 und 20 unter scheiden.
Das 5a,6a;17a,20-Dioxido-3ss,20-diacetoxy- 16a-methyl-pregnan-Isomerenpaar lässt sich durch fraktionierte Kristallisation aus Äther rein gewinnen. Der Schmelzpunkt des Gemisches der beiden Iso- meren, die sich nur durch die verschiedene Kon figuration in Stellung 20 unterscheiden, liegt je nach dem Verhältnis der beiden Isomeren zwischen 265 und 190 .
4 g des Isomerengemisches der 5a,6a;17a,20- Dioxido-3ss,20-diacetoxy-16a-methyl-pregnane, gelöst in 160 ml Methanol werden mit einer Lösung von 2 g Kaliumcarbonat in 40 ml Wasser versetzt. Die klare Reaktionsmischung wird 11/2 Stunden am Rück fluss gekocht und danach unter Rühren mit dem doppelten Volumen heissem Wasser verdünnt. Nach dem Abkühlen auf 0 wird das auskristallisierte Pro dukt filtriert, mit Wasser alkalifrei gewaschen und im Vakuum bei 80 getrocknet.
Das so ge wonnene 5a,6a-Oxido-3ss,17a-dihydroxv-16a-methyl- pregnan-20-on schmilzt bei 245 .
<I>Beispiel 2</I> 0,25g 5a,6a-Oxido-3ss,17a-dihydroxy-16a-methyl- pregnan-20-on, gelöst in 2,5 ml Pyridin, werden zu einem Gemisch aus 0,25 g Chromtrioxyd in 2,5 ml Pyridin gegossen. Die Reaktionsmischung wird gut durchgeschüttelt und 24 Stunden bei Zimmertempe ratur stehengelassen. Danach wird das Pyridin im Vakuum vorsichtig abgedampft, der Rückstand mit 100 ml Äther gründlich verrieben, die ätherische Lösung mit verdünnter Essigsäure, Natriumcarbonat und Wasser gewaschen, getrocknet und eingedampft.
Der amorphe Rückstand wird durch Anspritzen mit Äther zur Kristallisation gebracht, filtriert und mit wenig Äther gewaschen, wobei das 5a,6a-Oxido-16a- methyl-17a-hydroxy-pregnan-3,20-dion erhalten wird. <I>Beispiel 3</I> 3,3 g 5a,6a-Oxido-16a-methyl-17a-hydroxy-preg- nan-3,20-dion werden in 400 ml Benzol-Äther (1 : 1) gelöst, die Lösung mit 3,3 ml Bortrifluoridätherat ver setzt und das Reaktionsgemisch 8 Stunden bei Zim mertemperatur stehengelassen.
Nun wird die Reak tionslösung mit 5 0/miger wässriger Natriumbicarbonat- lösung und Wasser gewaschen, mit Magnesiumsulfat getrocknet und eingedampft. Reinigung durch Kri stallisation aus Aceton-Hexan führt zum 5a,17a-Di- hydroxy-6,ss-fluor-16a-methyl-pregnan-3,20-dion.
Behandelt man das gleiche Ausgangsmaterial statt mit Bortrifluoridätherat mit Salzsäuregas in Eisessig während 18 Stunden, dampft ein, wäscht säurefrei, trocknet und kristallisiert aus Aceton-Hexan um, so gewinnt man das 44-6a-Chlor-16a-methyl-17a- hydroxy-pregnen-3,20-dion.
Zur Überführung in das 17a-Acetat löst man 1 g J4-6a-Chlor-16a-methyl-17a-hydroxy-pregnen- 3,20-dion in 10 ml Acetanhydrid, gibt 120 mg p-Toluolsulfonsäure zu und lässt 24 Stunden bei Raumtemperatur stehen. Dann giesst man in Was ser, erwärmt kurz auf dem Wasserbad, filtriert und kristallisiert den getrockneten Rückstand aus Aceton- Hexan, wobei das 44-6a-Chlor-16a-methyl-17a- acetoxy-pregnen-3,20-dion erhalten wird.
In analoger Weise lassen sich höhere 17a-Ester, wie z. B. das 17a-Capronat von d4-6a-Chlor-16a- methyl-17a-hydroxy-pregnen-3,20-dion herstellen.
<I>Beispiel 4</I> 2,1 g 5a,6a-Oxido-3ss,17a-dihydroxy-16a-methyl- pregnan-20-on werden in 300 ml eines Gemisches aus Benzol und Äther (1 : 1) gelöst und mit 2,1 ml Borfluoridätherat behandelt. Nach 6 Stunden wird die Reaktionsmischung mit wässriger Natriumbicar- bonatlösung und dann mit Wasser gewaschen, mit Magnesiumsulfat getrocknet und im Vakuum ein gedampft.
Im Rückstand befindet sich das gewünschte 3ss,5a,17a-Trihydroxy 6ss-fluor-16a-methyl-pregnan- 20-on, das durch Oxydation in Aceton mit über schüssiger 8-n. Chromsäure bei 0 in das im Bei spiel 3 beschriebene 5a,17a-Dihydroxy-6ss-fluor-16a- methyl-pregnan-3,20-dion übergeführt werden kann. <I>Beispiel S</I> In eine Lösung von 1,6 g 5a,17a-Dihydroxy-6ss- fluor-16a-methyl-pregnan-3,20-dion in 16 ml Essig säure wird bei 15 während 2 Stunden trockenes Salzsäuregas eingeleitet und danach 18 Stunden bei Zimmertemperatur stehengelassen.
Die Reaktions gemisch wird nun mit Wasser verdünnt und mit Äther ausgeschüttelt. Die ätherische Lösung wird mit wässriger Bicarbonatlösung gewaschen, mit Ma gnesiumsulfat getrocknet und eingedampft. Das so gewonnene rohe d1-6a-Fluor-16a-methyl-17a-hy- droxy-pregnen-3,20-dion lässt sich durch Chroma- tographie an Silicagel reinigen.
Das oben beschriebene d4-6a-Fluor-16a-methyl- 17a-hydroxy-pregnen-3,20-dion lässt sich analog den Angaben von Beispiel 4 in 17-Stellung verestern. Man gewinnt z. B. in dieser Weise das 17a-Acetat, 17a-Propionat oder 17a-Capronat von J4-6a-Fluor- 16a-methyl-17a-hydroxy-pregnen-3,20-dion.
Process for the preparation of esters of new halopregnane compounds The subject of the present patent is a process for the preparation of esters of new 17a-hydroxypregnenes of the formula
EMI0001.0004
where X is fluorine or chlorine and R is an acyl radical of a carboxylic acid.
It consists of having a 45; 17 (20) -3fl, 20-diacyloxy-16a-methyl-pregnadiene of the formula
EMI0001.0009
where Ac denotes an acyl group, oxidized with a per acid, then hydrolyzed the acyloxy groups, in the 3,17a-dihydroxy-5a, 6a-oxido-16a-methyl-pregnan-20-ones obtained, the 3-hydroxy group is oxidized to the keto group and before or after this oxidation the 5a, 6a-oxido group to 6p,
5a-fluorohydrin or chlorohydrin opens, the 5a-hydroxyl group is split off with formation of the 4,5 double bond, the 6p-halogen compounds obtained isomerized to 6a-halogen compounds and at any reaction stage after the oxidation in 3-th positions - the 17a-hydroxy group is esterified. In the 44-3 won,
20-Dioxo-17a-acyloxy-16a-methyl-6a-fluoro- or -6a-chloro-pregnenen can also be introduced into a double bond in the 1,2-position.
The procedure is illustrated in the formula below:
EMI0002.0001
For the process according to the oxidation of the starting materials used z. B. organic peracids, especially perbenzoic acid, monoperphthalic acid or peracetic acid, in the presence of a suitable solvent such as ether and; or halogenated hydrocarbons.
The acyloxy groups in the 5,6; 17,20 diepoxides formed are advantageously hydrolyzed with alkaline agents. One uses z. B. Solutions of alkali metal carbonates, bicarbonates or hydroxides in aqueous methanol or ethanol, dioxane or tetrahydrofuran. In addition, amines, such as.
B. diethylamine, ethylenediamine or o-phenylenediamine, can be used. It is advisable to use the predominant amount of 5a, 6a-oxido-3ss, 17a-dihydroxy-16a-methyl-20-oxo-pregnane in the hydrolysis product by crystallization and / or chromatography on aluminum oxide from 5P, Separate 6ss isomers.
For the oxidation of the hydroxyl group in the 3-position to the keto group, such Oxy dationsmittel that leave the side chain unchanged, z. B. chromic acid-pyridine complex, or with kur zer reaction time and chromic acid-sulfuric acid-acetone mixture, also N-chloro- or N-bromo carboxamides or imides, z. B. bromosuccinimide or bromoacetamide in aqueous solutions, e.g. B.
aqueous acetone or pyridine.
The splitting of the 5a, 6a-epoxide to form the 6ss-fluorine or 6ss-chloro-5a-hydroxy compounds takes place, as mentioned, before or after the oxidation of the 3-hydroxy group to the 3-keto group. For this you can use chloric or hydrofluoric acid in a solvent medium, for.
B. in alcohols, ketones, ethers, halogenated hydrocarbons, such as methylene chloride or chloroform, preferably in lower aliphatic carboxylic acids such as glacial acetic acid or propionic acid, etc., or in mixtures of the solvents mentioned, advantageously at temperatures between 0-30.
Instead of hydrogen chloride or hydrogen fluoride, pyridine or collidine hydrochloride or boron trifluoride etherate in benzene can also be used to split the 5a, 6a-epoxide. In these reactions, the 5α-hydroxy compounds with a 6ss fluorine or chlorine atom are obtained. 3-Hydroxy compounds are now oxidized to the corresponding 3-ketones, it being possible to use the oxidizing agents listed above.
To split off water, the 3-oxo-5a-hydroxy-6ss-halogen compounds with bases, e.g. B. potassium hydroxide, or acids, e.g. B. hydrochloric acid, are treated. The 44-3-keto-6ss-halogen compounds are obtained. Depending on the used reaction conditions, e.g. B. Opening of the epoxy by means of hydrochloric acid gas in glacial acetic acid, the 44-3-keto-6a-halogen compounds can be formed in one reaction stage.
The isomerization of the J4-3-keto-6ss-halogen compounds to the 44-3-keto-6a- halogen compounds is expediently carried out using hydrogen chloride gas in glacial acetic acid.
The esters of the 17a-hydroxy compounds obtained are obtained by z. B. in well-ter manner with halides or anhydrides of z. B. aliphatic carboxylic acids, e.g. B. acetic, propionic, butyric acid, especially caproic acid, to set, advantageously in the presence of a catalyst such as pyridine, p-toluenesulfonic acid or perchloric acid.
The introduction of the 1,2 double bond in the 44-3,20-dioxo-17a-acyloxy-16a-methyl-pregnenen obtained, which have a fluorine or chlorine atom in the 6a-position, can be carried out by means of dehydrogenating selenium compounds, e.g. B. selenium dioxide or selenious acid, in a tertiary alcohol such as amylene hydrate or tert. Butanol, or by microbiological de-hydrogenation.
Various microorganisms known for this reaction are suitable for the microbiological dehydration, such as e.g. B. Di- dymella lycopersici, Corynebacterium simplex, Bacillus sphaericus, Mycobacterium lacticola, Fusarium solani, Calonectria decora.
The d5; 17 ("0) - 3,20-diacyloxy-16a-methyl-pregnadienes used as starting materials are new; they can be obtained by the process described in Swiss Patent No. 368490.
The 17a-esters obtained as end products and their d1-derivatives, such as 17a-acetates, 17a-capronates of 44-6a-fluoro-16a-methyl-17a-hydroxypregnen-3,20-dione, 44-6a-chloro-16a- methyl-17a-hydroxy-pregnen-3,20-dione, d1-4-6a-fluoro-16a-methyl-17a-hydroxy-pregnadiene-3,20-dione and 41,4-6a-chlorine-16a- methyl-17a-hydroxy-pregnad'ien-3,20-dione are characterized by a high progestative effect,
which is superior to that of the natural hormone progesterone.
In the examples below, which only describe embodiments of individual stages of the process according to the invention, the temperatures are given in degrees Celsius. <I> Example 1 </I> 4.1 g 45:17 (2o) -3ss, 20-diacetoxy-16a.-methyl-pregnadiene, dissolved in 30 ml ether, are mixed with 52 ml of a 0.575 molar, ethereal Phthalmonoperacid solution added and left to stand for 48 hours in the dark at room temperature,
after which the phthalic acid and excess phthalic monoperacid formed are removed by shaking with aqueous sodium carbonate solution. After the ethereal solution has been dried with magnesium sulfate and the solvent has evaporated, the residue is crystallized by trituration with methanol. The diepoxide obtained in this way is a mixture of the four possible isomers, which differ due to the configuration in positions 5, 6 and 20.
The 5a, 6a; 17a, 20-dioxido-3ss, 20-diacetoxy-16a-methyl-pregnane isomer pair can be obtained in pure form by fractional crystallization from ether. The melting point of the mixture of the two isomers, which differ only in their different configuration in position 20, is between 265 and 190, depending on the ratio of the two isomers.
4 g of the isomer mixture of 5a, 6a; 17a, 20-dioxido-3ss, 20-diacetoxy-16a-methyl-pregnane, dissolved in 160 ml of methanol, are mixed with a solution of 2 g of potassium carbonate in 40 ml of water. The clear reaction mixture is refluxed for 11/2 hours and then diluted with twice the volume of hot water while stirring. After cooling to 0, the product which has crystallized out is filtered, washed with water until free from alkali and dried at 80 in a vacuum.
The 5a, 6a-oxido-3ss, 17a-dihydroxv-16a-methyl-pregnan-20-one thus obtained melts at 245.
<I> Example 2 </I> 0.25 g of 5a, 6a-oxido-3ss, 17a-dihydroxy-16a-methyl-pregnan-20-one, dissolved in 2.5 ml of pyridine, become a mixture of 0.25 g chromium trioxide poured into 2.5 ml pyridine. The reaction mixture is shaken well and left to stand at room temperature for 24 hours. The pyridine is then carefully evaporated in vacuo, the residue is triturated thoroughly with 100 ml of ether, the ethereal solution is washed with dilute acetic acid, sodium carbonate and water, dried and evaporated.
The amorphous residue is made to crystallize by spraying with ether, filtered and washed with a little ether, the 5a, 6a-oxido-16a-methyl-17a-hydroxy-pregnane-3,20-dione being obtained. <I> Example 3 </I> 3.3 g of 5a, 6a-oxido-16a-methyl-17a-hydroxy-preg-nan-3,20-dione are dissolved in 400 ml of benzene ether (1: 1), the solution with 3.3 ml of boron trifluoride ether sets ver and the reaction mixture left to stand for 8 hours at room temperature.
The reaction solution is then washed with 50% aqueous sodium bicarbonate solution and water, dried with magnesium sulfate and evaporated. Purification by crystallization from acetone-hexane leads to 5a, 17a-dihydroxy-6, ss-fluoro-16a-methyl-pregnane-3,20-dione.
If the same starting material is treated with hydrochloric acid gas in glacial acetic acid instead of with boron trifluoride ether for 18 hours, evaporated, washed acid-free, dried and recrystallized from acetone-hexane, the 44-6a-chloro-16a-methyl-17a-hydroxy-pregnen is obtained -3,20-dione.
To convert into the 17a-acetate, 1 g of I4-6a-chloro-16a-methyl-17a-hydroxy-pregnen-3,20-dione is dissolved in 10 ml of acetic anhydride, 120 mg of p-toluenesulfonic acid are added and left for 24 hours at room temperature stand. It is then poured into water, warmed briefly on the water bath, filtered and the dried residue is crystallized from acetone-hexane, the 44-6a-chloro-16a-methyl-17a-acetoxy-pregnen-3,20-dione being obtained.
In an analogous manner, higher 17a esters, such as. B. produce the 17a-capronate of d4-6a-chloro-16a-methyl-17a-hydroxy-pregnen-3,20-dione.
<I> Example 4 </I> 2.1 g of 5a, 6a-oxido-3ss, 17a-dihydroxy-16a-methyl-pregnan-20-one are dissolved in 300 ml of a mixture of benzene and ether (1: 1) and treated with 2.1 ml of boron fluoride etherate. After 6 hours the reaction mixture is washed with aqueous sodium bicarbonate solution and then with water, dried with magnesium sulfate and evaporated in vacuo.
In the residue is the desired 3ss, 5a, 17a-trihydroxy 6ss-fluoro-16a-methyl-pregnan-20-one, which is obtained by oxidation in acetone with excess 8-n. Chromic acid at 0 can be converted into the 5a, 17a-dihydroxy-6ss-fluoro-16a-methyl-pregnane-3,20-dione described in Example 3. <I> Example S </I> In a solution of 1.6 g of 5a, 17a-dihydroxy-6ss-fluoro-16a-methyl-pregnane-3,20-dione in 16 ml of acetic acid is dry at 15 for 2 hours Hydrochloric acid gas introduced and then left to stand for 18 hours at room temperature.
The reaction mixture is now diluted with water and extracted with ether. The ethereal solution is washed with aqueous bicarbonate solution, dried with magnesium sulfate and evaporated. The crude d1-6a-fluoro-16a-methyl-17a-hydroxy-pregnen-3,20-dione obtained in this way can be purified by chromatography on silica gel.
The d4-6a-fluoro-16a-methyl-17a-hydroxy-pregnen-3,20-dione described above can be esterified in the 17-position analogously to the information in Example 4. One wins z. B. in this way the 17a-acetate, 17a-propionate or 17a-capronate of J4-6a-fluoro-16a-methyl-17a-hydroxy-pregnen-3,20-dione.
Claims (1)
Priority Applications (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CH6947959A CH376911A (en) | 1959-02-12 | 1959-02-12 | Process for the preparation of esters of new halogenpregnane compounds |
| DE19601418684 DE1418684A1 (en) | 1959-02-12 | 1960-01-29 | Process for the preparation of the former of new halogenpregnane compounds |
| BE587501A BE587501A (en) | 1959-02-12 | 1960-02-11 | Process for the preparation of esters of new halogenans, in particular of Delta <4> -3,20-diketo-6alpha-fluoro-on of Delta <4> -3,20-diketo-6alpha-chloro-16alpha-methyl- 17alpha, 21-dihydroxy-pregnenes, corresponding compounds having a double bond in position 1,2 and 21-acyloxy-compounds |
| BE587500A BE587500A (en) | 1959-02-12 | 1960-02-11 | Process for the preparation of Delta <4> -3,20-diketo-6alpha-fluoro- or Delta <4> -3,20-diketo-6alpha-chloro-16alpha-methyl-17alpha, 21-dihydroxy-pregnenes, compounds corresponding having a double bond in position 1,2 and 21-acyloxy compounds |
| GB511560A GB944842A (en) | 1959-02-12 | 1960-02-12 | Process for the manufacture of esters of halogen-pregnanes |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CH6947959A CH376911A (en) | 1959-02-12 | 1959-02-12 | Process for the preparation of esters of new halogenpregnane compounds |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CH376911A true CH376911A (en) | 1964-04-30 |
Family
ID=4529551
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CH6947959A CH376911A (en) | 1959-02-12 | 1959-02-12 | Process for the preparation of esters of new halogenpregnane compounds |
Country Status (1)
| Country | Link |
|---|---|
| CH (1) | CH376911A (en) |
-
1959
- 1959-02-12 CH CH6947959A patent/CH376911A/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US2838498A (en) | 6-fluoro-delta4-3-keto steroids and process for preparing same | |
| US2838496A (en) | 6-fluoro steroids and process for preparing same | |
| US3485852A (en) | 6-halo-6-dehydro-progesterones | |
| US2671084A (en) | 17(20)-oxido-3,11alpha, 20-triacyloxypregnanes | |
| US3050519A (en) | Cyclocarbonate esters of 16alpha, 17alpha-dihydroxypregnenes | |
| EP0003341B1 (en) | 11,17-substituted pregnanes, their preparation and application for the preparation of pharmaceutical compositions | |
| CH376911A (en) | Process for the preparation of esters of new halogenpregnane compounds | |
| US2838541A (en) | 6-fluoro-4-pregnenes and process for preparing same | |
| DD158778A5 (en) | PROCESS FOR PREPARING HALOGENATED STEROIDS | |
| DE1418684C (en) | Process for the production of delta 4 or delta 1.4 3.20 Dioxo 17 alpha acyloxy 16 alpha methyl 6 alpha fluor or 6 alpha chlorpregnenen | |
| US2838502A (en) | 6-fluoro steroids and process | |
| US3014030A (en) | 9alpha-methylpregnenes, pregnadienes and intermediates therefor | |
| US3261830A (en) | 6-keto-delta-19-nor-derivatives of cortical hormones | |
| US3060175A (en) | New method of hydroxylating steroids and products resulting therefrom | |
| US2884420A (en) | 6-fluoro-17 alpha, 21-epoxy-1,4-pregnadienes | |
| US3141029A (en) | 16alpha-alkoxy-6-dehydrocortical hormones | |
| US3008959A (en) | 16-alkoxylated steroid compounds and process | |
| DE2433178A1 (en) | PREGNAN SERIES ALKYLATED STEROIDS IN THE 21 POSITION | |
| DE1493344B1 (en) | Process for the preparation of 16 alpha-chloro- or -fluoro-17 (20) -pregnen-21-acid esters and 16 alpha-chloro- or -fluoro-17 alpha-hydroxy-20-keto-21-acyloxy compounds of the pregnane series obtainable therefrom | |
| DE1418684B (en) | Process for the production of Delta high 4 or Delta high 1.4 3.20 Dioxo 17 alpha acyloxy 16 alpha methyl 6 alpha fluor or 6 alpha chlorpregnenen | |
| DE944248C (en) | Process for the preparation of esters of 4-pregnen-11, 17ª ‡, 21-triol-3, 20-dione or of 21-esters of 4-pregnen-17ª ‡, 21-diol-3, 11, 20-trione | |
| US2929814A (en) | 3, 20 diketals derivatives of 9alpha-halo 16-hydroxy-hydrocortisone and cortisone | |
| AT212500B (en) | Process for the production of new haloandrostenes | |
| US3232967A (en) | 16,21-dihydroxy-4,17(20)-pregnadiene-3,11-dione and process for production thereof | |
| US3123600A (en) | Reaction sequence b |